Dr Timothy Eviston MBBS PhD FRACS
Chief Executive Officer.
Dr Eviston is a Sydney based surgeon, scientist and entrepreneur. Technology, relationships and innovations underpinning Intravital were developed by Dr Eviston during his PhD studies at UNSW. He is an inventor on a number of patents including Intravital's core technologies.
Dr Eviston specialises in interdisciplinary science, team building and technology integration. From a clinical perspective, Dr Eviston has a special interest in advanced head and neck cancer surgery and reconstruction. In his research capacity Dr Eviston has pioneered techniques and therapies in surgical nerve injury and nerve monitoring. He has presented nationally and internationally and has published in high impact medical and surgical journals. His research collaborations extend across neurobiology, clinical neurophysiology, biomedical engineering and cancer research.
"Intravital's mission is to meaningfully impact the lives of patients. I strongly belive that a future without chronic pain, nerve injury and loss of function after surgery is within our grasp. A patient undergoing surgery should have confidence that they will feel well after their surgery."
Prof. Arun Krishnan MBBS PhD FRACP
Chief Medical Officer.
Professor Krishnan is Professor of Medicine at UNSW and is recognised globally as a leader in peripheral nerve injury research. He is a neurologist, clinical neurophysiologist and Head of the Neuromuscular Disease and Multiple Sclerosis Research Group at UNSW. As one of UNSW's youngest full professors, he leads a large research team that has pioneered the development of early biomarkers for peripheral nerve disorders.
Prof Krishnan has extensive experience with running and developing clinical trials and has strong industry ties, working with a number of multinational pharmaceutical and medical device companies globally. He is co-inventor on neuroprotective and nerve injury patents and has been an expert advisor to Industry partners in regulatory matters, both in Australia and internationally. He has published more than 110 academic papers, with many in high impact medical journals.
Dr Lindsay Wu PhD
Chief Scientific Officer.
Dr Wu is a leading scientist and biotechnology entrepreneur. He is a Cancer Institute NSW Fellow and runs the Laboratory for Ageing Research at UNSW, the partner lab to Harvard's ageing research laboratory. His research focuses on novel compounds and strategies to improve cell survival and function in the face of insults such as old age, chemotherapy, and mechanical stress. He is a founding director of Metro Biotech NSW Pty Ltd and Jumpstart Fertility Pty Ltd and is an inventor on 5 patents.
Dr Wu is a regular speaker at international meetings and is a regular provider of scientific commentary to mainstream media outlets. He recently chaired the Australian Biology of Ageing Conference (ABAC) in Sydney and is recognised as one of the emerging molecular biology experts in the field.